摘要
目的分析探讨瑞舒伐他汀对脑梗死的治疗效果。方法随机选取我院在2018年2月-2018年8月就诊的脑梗死患者共80例作为研究对象进行研究分析,按照随机数字表法将其分为对照组和研究组各40例,对照组患者给予阿托伐他汀治疗,研究组患者给予瑞舒伐他汀治疗,研究观察两组患者的血流动力学情况、神经功能缺损评分。结果研究组的红细胞聚集指数、全血高切粘度、全血低切粘度、纤维蛋白质指标均优于对照组(P<0.05);治疗前,两组患者神经功能缺损评分差异无统计学意义(P>0.05)。治疗后,研究组神经功能缺损评分较对照组来说明显降低[(10.34±2.65)分VS(23.01±3.56)分,P<0.05],差异对比具有统计学意义。结论瑞舒伐他汀对脑梗死的治疗具有积极的效果,可显著改善患者的神经功能和血流动力学情况,提高患者的生活质量,值得在临床上进一步推广应用。
Objective To investigate the therapeutic effect of rosuvastatin on cerebral infarction.Methods A total of 80 patients with cerebral infarction who were treated in our hospital from February 2018 to August 2018 were randomly selected as the study subjects.They were divided into control group and study group according to the random number table method.Patients in the control group were treated with atorvastatin,and patients in the study group were treated with rosuvastatin.The hemodynamics and neurological deficit scores were observed in the two groups.Results The red blood cell aggregation index,whole blood high-viscosity,whole blood low-cut viscosity and fiber protein index of the study group were better than the control group(P<0.05).There was no significant difference in neurological deficit score between the two groups before treatment(P>0.05).After treatment,the neurological deficit score of the study group was significantly lower than that of the control group[(10.34±2.65)points vs(23.01±3.56)points,P<0.05],and the difference was statistically significant.Conclusion Rosuvastatin has a positive effect on the treatment of cerebral infarction,can significantly improve the patient’s neurological function and hemodynamics,improve the quality of life of patients,and is worthy of further clinical application.
作者
臧志忠
Zang Zhizhong(Danyang people's hospital,212300)
出处
《辽宁医学杂志》
2019年第6期46-48,共3页
Medical Journal of Liaoning
关键词
瑞舒伐他汀
脑梗死
临床价值
Rosuvastatin
Cerebral infarction
Clinical value
